Drugmaker uniQure reported the results of its small but “groundbreaking” Phase I/II study this week, finding that a high dose of its AMT-130 therapy slowed disease progression by 75% after 36 months.
A bid to stop two council-run care homes for dementia patients from being transferred to the private sector has been heard at ...
A green Mediterranean diet, which is a variation of the Med diet that includes green tea and the Asian aquatic plant Mankai, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback